KIAA1217, SLC44A1, INPP5B, and SDK1 were reversely correlated with some miRNAs not affecting patient survival (Fig. 6E), which shows these are potential therapeutic targets for pancreatic cancer. This evidence concerns the gene KIAA1217 and familial pancreatic carcinoma.